Lunai Bioworks Inc.

11/12/2026 | Press release | Distributed by Public on 11/12/2026 16:17

Termination Notice (Form 15-12G)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-38758

LUNAI BIOWORKS, INC.

(Exact name of registrant as specified in its charter)

3400 Cottage Way, Suite G2, #32562, Sacramento, California 95825; (424) 222-9301

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1) ☒
Rule 12g-4(a)(2) ☐
Rule 12h-3(b)(1)(i) ☐
Rule 12h-3(b)(1)(ii) ☐
Rule 15d-6 ☒
Rule 15d-22(b) ☐

Approximate number of holders of record as of the certification or notice date: 231

Pursuant to the requirements of the Securities Exchange Act of 1934, Lunai Bioworks, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: November 12, 2026 LUNAI BIOWORKS, INC.
By: /s/ David Weinstein
Name: David Weinstein
Title: Chief Executive Officer
Lunai Bioworks Inc. published this content on November 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 12, 2026 at 22:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]